Holdings of VanEck Pharmaceutical ETF
ISIN US92189F6925
VanEck ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 1.3B $ including 1.3B $ in equities, 99.7 %
- Positions
- 25 in 8 countries
- Top ten
- 71.8 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 261,452 | 240.5M $ | 18.70 % |
| 2 | Novartis AG | 905,997 | 138.4M $ | 10.76 % |
| 3 | Merck & Co Inc | 1,034,834 | 124.5M $ | 9.68 % |
| 4 | Pfizer Inc | 2,393,884 | 67.2M $ | 5.23 % |
| 5 | Novo Nordisk A/S | 1,683,055 | 61.9M $ | 4.81 % |
| 6 | Sanofi SA | 1,262,013 | 60.8M $ | 4.73 % |
| 7 | Bristol-Myers Squibb Co | 980,623 | 59.5M $ | 4.62 % |
| 8 | GSK PLC | 1,066,504 | 58.9M $ | 4.58 % |
| 9 | AstraZeneca PLC | 286,859 | 56.6M $ | 4.40 % |
| 10 | Johnson & Johnson | 228,209 | 55.8M $ | 4.34 % |
| 11 | McKesson Corp | 62,952 | 54.5M $ | 4.24 % |
| 12 | AbbVie Inc | 243,557 | 53M $ | 4.12 % |
| 13 | Cencora Inc | 152,957 | 48M $ | 3.74 % |
| 14 | Zoetis Inc | 378,012 | 44.7M $ | 3.47 % |
| 15 | Haleon PLC | 4,134,619 | 41.4M $ | 3.22 % |
| 16 | Takeda Pharmaceutical Co Ltd | 2,185,449 | 40.5M $ | 3.15 % |
| 17 | Teva Pharmaceutical Industries Ltd | 1,208,266 | 36.4M $ | 2.83 % |
| 18 | Viatris Inc | 855,028 | 11.6M $ | 0.90 % |
| 19 | Jazz Pharmaceuticals PLC | 54,455 | 10.3M $ | 0.80 % |
| 20 | Axsome Therapeutics Inc | 39,103 | 6.6M $ | 0.51 % |
| 21 | Elanco Animal Health Inc | 190,027 | 4.5M $ | 0.35 % |
| 22 | Corcept Therapeutics Inc | 70,860 | 2.9M $ | 0.22 % |
| 23 | Bausch Health Cos Inc | 247,078 | 1.3M $ | 0.10 % |
| 24 | Organon & Co | 210,370 | 1.3M $ | 0.10 % |
| 25 | Perrigo Co PLC | 84,179 | 904.1K $ | 0.07 % |
Sector breakdown
- Health care 92.1 %
- Consumer staples 3.2 %
- Unattributed 4.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 71.2 %
- United Kingdom 12.2 %
- Denmark 4.8 %
- France 4.7 %
- Japan 3.2 %
- Israel 2.8 %
- Ireland 0.9 %
- Canada 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 15 | 912.8M $ | 71.22 % |
| 2 | United Kingdom | 3 | 156.8M $ | 12.24 % |
| 3 | Denmark | 1 | 61.9M $ | 4.83 % |
| 4 | France | 1 | 60.8M $ | 4.74 % |
| 5 | Japan | 1 | 40.5M $ | 3.16 % |
| 6 | Israel | 1 | 36.4M $ | 2.84 % |
| 7 | Ireland | 2 | 11.2M $ | 0.87 % |
| 8 | Canada | 1 | 1.3M $ | 0.10 % |
Cite this page
Titelia. "Holdings of VanEck Pharmaceutical ETF". https://titelia.com/en/funds/S000034409